
Global Next-Generation Sequencing (NGS) Kits Market Outlook and Growth Opportunities 2025
Description
Summary
According to APO Research, the global Next-Generation Sequencing (NGS) Kits market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Next-Generation Sequencing (NGS) Kits is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Next-Generation Sequencing (NGS) Kits is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Next-Generation Sequencing (NGS) Kits market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Next-Generation Sequencing (NGS) Kits is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Next-Generation Sequencing (NGS) Kits market include Amoydxmed, Foundation Medicine, Illumina, MSKCC, Novogene, Nanjing Geneseeq, Burning Rock Biotech and Thermo Fisher Scientific, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Next-Generation Sequencing (NGS) Kits, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Next-Generation Sequencing (NGS) Kits, also provides the sales of main regions and countries. Of the upcoming market potential for Next-Generation Sequencing (NGS) Kits, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Next-Generation Sequencing (NGS) Kits sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Next-Generation Sequencing (NGS) Kits market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Next-Generation Sequencing (NGS) Kits sales, projected growth trends, production technology, application and end-user industry.
Next-Generation Sequencing (NGS) Kits Segment by Company
Amoydxmed
Foundation Medicine
Illumina
MSKCC
Novogene
Nanjing Geneseeq
Burning Rock Biotech
Thermo Fisher Scientific
Next-Generation Sequencing (NGS) Kits Segment by Type
BRAF
BRCA
EGFR
Others
Next-Generation Sequencing (NGS) Kits Segment by Application
Research Organizations
Hospitals and Clinics
Biopharma Companies
Others
Next-Generation Sequencing (NGS) Kits Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Next-Generation Sequencing (NGS) Kits status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Next-Generation Sequencing (NGS) Kits market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Next-Generation Sequencing (NGS) Kits significant trends, drivers, influence factors in global and regions.
6. To analyze Next-Generation Sequencing (NGS) Kits competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next-Generation Sequencing (NGS) Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Next-Generation Sequencing (NGS) Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next-Generation Sequencing (NGS) Kits.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Next-Generation Sequencing (NGS) Kits market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Next-Generation Sequencing (NGS) Kits industry.
Chapter 3: Detailed analysis of Next-Generation Sequencing (NGS) Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Next-Generation Sequencing (NGS) Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Next-Generation Sequencing (NGS) Kits in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
According to APO Research, the global Next-Generation Sequencing (NGS) Kits market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.
The North American market for Next-Generation Sequencing (NGS) Kits is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Asia-Pacific market for Next-Generation Sequencing (NGS) Kits is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
In China, the Next-Generation Sequencing (NGS) Kits market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The Europe market for Next-Generation Sequencing (NGS) Kits is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Major global companies in the Next-Generation Sequencing (NGS) Kits market include Amoydxmed, Foundation Medicine, Illumina, MSKCC, Novogene, Nanjing Geneseeq, Burning Rock Biotech and Thermo Fisher Scientific, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Next-Generation Sequencing (NGS) Kits, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Next-Generation Sequencing (NGS) Kits, also provides the sales of main regions and countries. Of the upcoming market potential for Next-Generation Sequencing (NGS) Kits, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Next-Generation Sequencing (NGS) Kits sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Next-Generation Sequencing (NGS) Kits market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Next-Generation Sequencing (NGS) Kits sales, projected growth trends, production technology, application and end-user industry.
Next-Generation Sequencing (NGS) Kits Segment by Company
Amoydxmed
Foundation Medicine
Illumina
MSKCC
Novogene
Nanjing Geneseeq
Burning Rock Biotech
Thermo Fisher Scientific
Next-Generation Sequencing (NGS) Kits Segment by Type
BRAF
BRCA
EGFR
Others
Next-Generation Sequencing (NGS) Kits Segment by Application
Research Organizations
Hospitals and Clinics
Biopharma Companies
Others
Next-Generation Sequencing (NGS) Kits Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Next-Generation Sequencing (NGS) Kits status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Next-Generation Sequencing (NGS) Kits market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Next-Generation Sequencing (NGS) Kits significant trends, drivers, influence factors in global and regions.
6. To analyze Next-Generation Sequencing (NGS) Kits competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next-Generation Sequencing (NGS) Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Next-Generation Sequencing (NGS) Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next-Generation Sequencing (NGS) Kits.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Next-Generation Sequencing (NGS) Kits market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Next-Generation Sequencing (NGS) Kits industry.
Chapter 3: Detailed analysis of Next-Generation Sequencing (NGS) Kits manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Next-Generation Sequencing (NGS) Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Next-Generation Sequencing (NGS) Kits in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Table of Contents
196 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Next-Generation Sequencing (NGS) Kits Sales Value (2020-2031)
- 1.2.2 Global Next-Generation Sequencing (NGS) Kits Sales Volume (2020-2031)
- 1.2.3 Global Next-Generation Sequencing (NGS) Kits Sales Average Price (2020-2031)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
- 2 Next-Generation Sequencing (NGS) Kits Market Dynamics
- 2.1 Next-Generation Sequencing (NGS) Kits Industry Trends
- 2.2 Next-Generation Sequencing (NGS) Kits Industry Drivers
- 2.3 Next-Generation Sequencing (NGS) Kits Industry Opportunities and Challenges
- 2.4 Next-Generation Sequencing (NGS) Kits Industry Restraints
- 3 Next-Generation Sequencing (NGS) Kits Market by Company
- 3.1 Global Next-Generation Sequencing (NGS) Kits Company Revenue Ranking in 2024
- 3.2 Global Next-Generation Sequencing (NGS) Kits Revenue by Company (2020-2025)
- 3.3 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Company (2020-2025)
- 3.4 Global Next-Generation Sequencing (NGS) Kits Average Price by Company (2020-2025)
- 3.5 Global Next-Generation Sequencing (NGS) Kits Company Ranking (2023-2025)
- 3.6 Global Next-Generation Sequencing (NGS) Kits Company Manufacturing Base and Headquarters
- 3.7 Global Next-Generation Sequencing (NGS) Kits Company Product Type and Application
- 3.8 Global Next-Generation Sequencing (NGS) Kits Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Next-Generation Sequencing (NGS) Kits Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
- 3.9.3 2024 Next-Generation Sequencing (NGS) Kits Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
- 4 Next-Generation Sequencing (NGS) Kits Market by Type
- 4.1 Next-Generation Sequencing (NGS) Kits Type Introduction
- 4.1.1 BRAF
- 4.1.2 BRCA
- 4.1.3 EGFR
- 4.1.4 Others
- 4.2 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Type
- 4.2.1 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Type (2020-2031)
- 4.2.3 Global Next-Generation Sequencing (NGS) Kits Sales Volume Share by Type (2020-2031)
- 4.3 Global Next-Generation Sequencing (NGS) Kits Sales Value by Type
- 4.3.1 Global Next-Generation Sequencing (NGS) Kits Sales Value by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Next-Generation Sequencing (NGS) Kits Sales Value by Type (2020-2031)
- 4.3.3 Global Next-Generation Sequencing (NGS) Kits Sales Value Share by Type (2020-2031)
- 5 Next-Generation Sequencing (NGS) Kits Market by Application
- 5.1 Next-Generation Sequencing (NGS) Kits Application Introduction
- 5.1.1 Research Organizations
- 5.1.2 Hospitals and Clinics
- 5.1.3 Biopharma Companies
- 5.1.4 Others
- 5.2 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Application
- 5.2.1 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Next-Generation Sequencing (NGS) Kits Sales Volume by Application (2020-2031)
- 5.2.3 Global Next-Generation Sequencing (NGS) Kits Sales Volume Share by Application (2020-2031)
- 5.3 Global Next-Generation Sequencing (NGS) Kits Sales Value by Application
- 5.3.1 Global Next-Generation Sequencing (NGS) Kits Sales Value by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Next-Generation Sequencing (NGS) Kits Sales Value by Application (2020-2031)
- 5.3.3 Global Next-Generation Sequencing (NGS) Kits Sales Value Share by Application (2020-2031)
- 6 Next-Generation Sequencing (NGS) Kits Regional Sales and Value Analysis
- 6.1 Global Next-Generation Sequencing (NGS) Kits Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Next-Generation Sequencing (NGS) Kits Sales by Region (2020-2031)
- 6.2.1 Global Next-Generation Sequencing (NGS) Kits Sales by Region: 2020-2025
- 6.2.2 Global Next-Generation Sequencing (NGS) Kits Sales by Region (2026-2031)
- 6.3 Global Next-Generation Sequencing (NGS) Kits Sales Value by Region: 2020 VS 2024 VS 2031
- 6.4 Global Next-Generation Sequencing (NGS) Kits Sales Value by Region (2020-2031)
- 6.4.1 Global Next-Generation Sequencing (NGS) Kits Sales Value by Region: 2020-2025
- 6.4.2 Global Next-Generation Sequencing (NGS) Kits Sales Value by Region (2026-2031)
- 6.5 Global Next-Generation Sequencing (NGS) Kits Market Price Analysis by Region (2020-2025)
- 6.6 North America
- 6.6.1 North America Next-Generation Sequencing (NGS) Kits Sales Value (2020-2031)
- 6.6.2 North America Next-Generation Sequencing (NGS) Kits Sales Value Share by Country, 2024 VS 2031
- 6.7 Europe
- 6.7.1 Europe Next-Generation Sequencing (NGS) Kits Sales Value (2020-2031)
- 6.7.2 Europe Next-Generation Sequencing (NGS) Kits Sales Value Share by Country, 2024 VS 2031
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Next-Generation Sequencing (NGS) Kits Sales Value (2020-2031)
- 6.8.2 Asia-Pacific Next-Generation Sequencing (NGS) Kits Sales Value Share by Country, 2024 VS 2031
- 6.9 South America
- 6.9.1 South America Next-Generation Sequencing (NGS) Kits Sales Value (2020-2031)
- 6.9.2 South America Next-Generation Sequencing (NGS) Kits Sales Value Share by Country, 2024 VS 2031
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Next-Generation Sequencing (NGS) Kits Sales Value (2020-2031)
- 6.10.2 Middle East & Africa Next-Generation Sequencing (NGS) Kits Sales Value Share by Country, 2024 VS 2031
- 7 Next-Generation Sequencing (NGS) Kits Country-level Sales and Value Analysis
- 7.1 Global Next-Generation Sequencing (NGS) Kits Sales by Country: 2020 VS 2024 VS 2031
- 7.2 Global Next-Generation Sequencing (NGS) Kits Sales Value by Country: 2020 VS 2024 VS 2031
- 7.3 Global Next-Generation Sequencing (NGS) Kits Sales by Country (2020-2031)
- 7.3.1 Global Next-Generation Sequencing (NGS) Kits Sales by Country (2020-2025)
- 7.3.2 Global Next-Generation Sequencing (NGS) Kits Sales by Country (2026-2031)
- 7.4 Global Next-Generation Sequencing (NGS) Kits Sales Value by Country (2020-2031)
- 7.4.1 Global Next-Generation Sequencing (NGS) Kits Sales Value by Country (2020-2025)
- 7.4.2 Global Next-Generation Sequencing (NGS) Kits Sales Value by Country (2026-2031)
- 7.5 USA
- 7.5.1 USA Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.5.2 USA Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.5.3 USA Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.6 Canada
- 7.6.1 Canada Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.6.2 Canada Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Canada Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.7 Mexico
- 7.6.1 Mexico Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.6.2 Mexico Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.6.3 Mexico Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.8 Germany
- 7.8.1 Germany Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.8.2 Germany Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.8.3 Germany Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.9 France
- 7.9.1 France Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.9.2 France Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.9.3 France Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.10 U.K.
- 7.10.1 U.K. Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.10.2 U.K. Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.10.3 U.K. Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.11 Italy
- 7.11.1 Italy Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.11.2 Italy Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.11.3 Italy Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.12 Spain
- 7.12.1 Spain Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.12.2 Spain Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.12.3 Spain Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.13 Russia
- 7.13.1 Russia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.13.2 Russia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.13.3 Russia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.14 Netherlands
- 7.14.1 Netherlands Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.14.2 Netherlands Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.14.3 Netherlands Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.15.2 Nordic Countries Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.15.3 Nordic Countries Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.16 China
- 7.16.1 China Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.16.2 China Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.16.3 China Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.17 Japan
- 7.17.1 Japan Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.17.2 Japan Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.17.3 Japan Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.18 South Korea
- 7.18.1 South Korea Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.18.2 South Korea Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.18.3 South Korea Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.19 India
- 7.19.1 India Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.19.2 India Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.19.3 India Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.20 Australia
- 7.20.1 Australia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.20.2 Australia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.20.3 Australia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.21.2 Southeast Asia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.21.3 Southeast Asia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.22 Brazil
- 7.22.1 Brazil Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.22.2 Brazil Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.22.3 Brazil Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.23 Argentina
- 7.23.1 Argentina Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.23.2 Argentina Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.23.3 Argentina Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.24 Chile
- 7.24.1 Chile Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.24.2 Chile Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.24.3 Chile Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.25 Colombia
- 7.25.1 Colombia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.25.2 Colombia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.25.3 Colombia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.26 Peru
- 7.26.1 Peru Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.26.2 Peru Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.26.3 Peru Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.27.2 Saudi Arabia Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.27.3 Saudi Arabia Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.28 Israel
- 7.28.1 Israel Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.28.2 Israel Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.28.3 Israel Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.29 UAE
- 7.29.1 UAE Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.29.2 UAE Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.29.3 UAE Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.30 Turkey
- 7.30.1 Turkey Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.30.2 Turkey Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.30.3 Turkey Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.31 Iran
- 7.31.1 Iran Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.31.2 Iran Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.31.3 Iran Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 7.32 Egypt
- 7.32.1 Egypt Next-Generation Sequencing (NGS) Kits Sales Value Growth Rate (2020-2031)
- 7.32.2 Egypt Next-Generation Sequencing (NGS) Kits Sales Value Share by Type, 2024 VS 2031
- 7.32.3 Egypt Next-Generation Sequencing (NGS) Kits Sales Value Share by Application, 2024 VS 2031
- 8 Company Profiles
- 8.1 Amoydxmed
- 8.1.1 Amoydxmed Comapny Information
- 8.1.2 Amoydxmed Business Overview
- 8.1.3 Amoydxmed Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2020-2025)
- 8.1.4 Amoydxmed Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.1.5 Amoydxmed Recent Developments
- 8.2 Foundation Medicine
- 8.2.1 Foundation Medicine Comapny Information
- 8.2.2 Foundation Medicine Business Overview
- 8.2.3 Foundation Medicine Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2020-2025)
- 8.2.4 Foundation Medicine Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.2.5 Foundation Medicine Recent Developments
- 8.3 Illumina
- 8.3.1 Illumina Comapny Information
- 8.3.2 Illumina Business Overview
- 8.3.3 Illumina Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2020-2025)
- 8.3.4 Illumina Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.3.5 Illumina Recent Developments
- 8.4 MSKCC
- 8.4.1 MSKCC Comapny Information
- 8.4.2 MSKCC Business Overview
- 8.4.3 MSKCC Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2020-2025)
- 8.4.4 MSKCC Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.4.5 MSKCC Recent Developments
- 8.5 Novogene
- 8.5.1 Novogene Comapny Information
- 8.5.2 Novogene Business Overview
- 8.5.3 Novogene Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2020-2025)
- 8.5.4 Novogene Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.5.5 Novogene Recent Developments
- 8.6 Nanjing Geneseeq
- 8.6.1 Nanjing Geneseeq Comapny Information
- 8.6.2 Nanjing Geneseeq Business Overview
- 8.6.3 Nanjing Geneseeq Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2020-2025)
- 8.6.4 Nanjing Geneseeq Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.6.5 Nanjing Geneseeq Recent Developments
- 8.7 Burning Rock Biotech
- 8.7.1 Burning Rock Biotech Comapny Information
- 8.7.2 Burning Rock Biotech Business Overview
- 8.7.3 Burning Rock Biotech Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2020-2025)
- 8.7.4 Burning Rock Biotech Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.7.5 Burning Rock Biotech Recent Developments
- 8.8 Thermo Fisher Scientific
- 8.8.1 Thermo Fisher Scientific Comapny Information
- 8.8.2 Thermo Fisher Scientific Business Overview
- 8.8.3 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Kits Sales, Value and Gross Margin (2020-2025)
- 8.8.4 Thermo Fisher Scientific Next-Generation Sequencing (NGS) Kits Product Portfolio
- 8.8.5 Thermo Fisher Scientific Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Next-Generation Sequencing (NGS) Kits Value Chain Analysis
- 9.1.1 Next-Generation Sequencing (NGS) Kits Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Next-Generation Sequencing (NGS) Kits Sales Mode & Process
- 9.2 Next-Generation Sequencing (NGS) Kits Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Next-Generation Sequencing (NGS) Kits Distributors
- 9.2.3 Next-Generation Sequencing (NGS) Kits Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.